PUJA PATEL: Open Payments
NPI 1306590344 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $189 · 2025 $452
Food & beverage: $375Education: $77
| Company | Payments | Amount |
|---|---|---|
| Penumbra, Inc. | 1 | $141 |
| Janssen Biotech, Inc. | 2 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| GENZYME CORPORATION | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
Products named: Indigo System, TREMFYA, ENTYVIO, DUPIXENT, REZDIFFRA, XIFAXAN, IQIRVO, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
